Programmed Cell Death Ligand 1-Induced Coma From Diffuse Cerebritis

J Oncol Pract. 2018 Feb;14(2):134-135. doi: 10.1200/JOP.2017.024992. Epub 2017 Oct 10.

Authors

Ploa Desforges¹, Khashayar Esfahani¹, Nathaniel Bouganim¹

Affiliation

¹ McGill University Health Center, Montreal, Quebec, Canada.

PMID: 29016224
DOI: 10.1200/JOP.2017.024992

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antineoplastic Agents, Immunological / adverse effects*
Antineoplastic Agents, Immunological / therapeutic use
B7-H1 Antigen / antagonists & inhibitors*
Biomarkers
Coma / diagnosis*
Coma / etiology*
Coma / therapy
Electroencephalography
Female
Humans
Immunosuppressive Agents / therapeutic use
Magnetic Resonance Imaging
Meningitis / complications*
Meningitis / etiology*
Molecular Targeted Therapy / adverse effects*
Symptom Assessment
Treatment Outcome

Substances

Antineoplastic Agents, Immunological
B7-H1 Antigen
Biomarkers
CD274 protein, human
Immunosuppressive Agents